Pure Global
NCT06137209

Colonization of Skin by M. Luteus Q24 Probiotic

Assessment of Colonisation and Skin Quality Parameter Improvement by Probiotic Micrococcus Luteus Q24 Serum in Healthy Adults
BLIS Technologies Limited·ClinicalTrials.gov·otherRecruitment Completed
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Microbial Colonization
Drug/Device/Intervention
Active Comparator: Study Group A: Blis Q24 Serum at higher dose
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
BLIS Technologies Limited
Location
Dunedin, New Zealand
Timeline & enrollment
Phase
N/A
Start date
Oct 02, 2023
End date
Mar 15, 2024
Enrollment
20 participants
Primary outcome

Change in microbial composition following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days,Change in skin quality parameters following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days,Change in microbial composition following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days,Change in skin quality parameters following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 11 days,Change in microbial composition following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days,Change in skin quality parameters following application of 1e7 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days,Change in microbial composition following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days,Change in skin quality parameters following application of 1e6 cfu per dose Micrococcus luteus Q24 in serum from Day 0 (baseline) to 30 days,Change in microbial composition post 7 days of last application of 1e7 cfu of Micrococcus luteus Q24 in serum.,Change in skin quality parameters post 7 days of last application of 1e7 cfu of Micrococcus luteus Q24 in serum.,Change in microbial composition post 7 days of last application of 1e6 cfu of Micrococcus luteus Q24 in serum.,Change in skin quality parameters post 7 days of last application of 1e6 cfu of Micrococcus luteus Q24 in serum.

Summary

The purpose of this study is to evaluate the skin quality improvement and colonization
 efficacy following the application of probiotic Micrococcus luteus Q24 (BLIS Q24) to the face
 from a serum format in healthy adults.

ICD-10 classifications
Bacterial infection of unspecified siteOther bacterial infections of unspecified siteBacterial, viral and other infectious agentsCholeraOther specified bacterial intestinal infections
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06137209
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06137209 through Pure Global AI's free database. This phase not specified trial is sponsored by BLIS Technologies Limited and is currently Recruitment Completed. The study focuses on Microbial Colonization. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.